Homepage
Upcoming Science Forums
Our WuXi Science Forums kick off in September with multiple events in the US and EU. These forums will feature guest speakers, engaging panel discussions, networking lunches, and poster sessions.
Upcoming Webinar: Strategies for Advancing Molecular Glue Drug Discovery
This expert-led presentation will introduce WuXi Biology’s end-to-end molecular glue discovery and evaluation platform.
Upcoming Webinar: Innovative Technologies in Early Drug Discovery
Join us for an exclusive webinar where experts from WuXi Biology will unveil the latest innovative technologies and products in small molecule and new molecule drug discovery.
WuXi Biology
A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic
Enabling Unbounded Possibilities
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and beyond. Our world-class discovery platform is backed by nearly 3,000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules and oligonucleotides to peptides and antibodies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.
Speak with a SpecialistTarget Discovery to Candidate Selection and Beyond
Supporting stand-alone and integrated projects
Comprehensive platform from target ID to drug candidates
Target Identification and Validation
Finding druggable targets
Comprehensive coverage of target classes and therapeutic modalities
Hit Identification
Screening services to accelerate drug discovery
Integrated platform with diverse methods to identify hit compounds
Hit Validation and Early Optimization
Confirming chemistry tractability
In vitro screening platform to support medicinal chemistry
Lead Discovery Services
Enhancing the most promising compounds
In vivo services to accelerate drug discovery
Preclinical Drug Development
Enabling the selection of the best candidates
Integrated platform for preclinical R&D to accelerate timelines
Investigational New Drug Discovery
Comprehensive IND enabling testing platform
Supporting clients from research to market
Latest Science
Latest Presentation
Combination Therapies in a Mouse MASH Model
Combination Therapies in a Mouse Model of MASH
VIEW PresentationLatest White Paper
Strategies to Accelerate the Development of Antibody-Drug Conjugates
Strategies to Accelerate the Development of Antibody-Drug Conjugates
VIEW White PaperLatest Poster
Development of Rodent Models for Diabetic Neuropathy
Development of Rodent Models for Diabetic Neuropathy
VIEW PosterLatest Poster
STZ-Induced Diabetic Retinopathy Models
STZ-Induced Diabetic Retinopathy Models
VIEW PosterOvercoming PARP Inhibitor Resistance in an Olaparib-Induced Model
VIEW PosterEffects of Incretin-Based Therapies on Metabolic and Muscular Homeostasis
VIEW PosterTargeting MC4R with Setmelanotide Improves Metabolic Parameters in DIO Mice
VIEW PosterTargeting the CB1 Receptor for Enhanced Obesity Management
VIEW PosterLatest Publication
Native Mass Spectrometry Facilitates Validation of DEL Hits
Native Mass Spectrometry Facilitates Validation of DEL Hits
VIEW PublicationLatest Publication
Discovery of a Novel CD39 Inhibitor by DEL...
Discovery of a Novel CD39 Inhibitor by DEL Screening
VIEW Publication